62921-37-3 Usage
Description
(12Z,14E,24Z)-5,6,11,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1-oxo-9-propyl-1,2,9,10-tetrahydro-2,8-(epoxytetradeca[1,11,13]trieno)[1]benzofuro[4,5-g]quinazolin-21-yl acetate is a complex organic chemical compound that is a derivative of benzofuro[4,5-g]quinazolin-21-yl acetate. It features a unique molecular structure with multiple hydroxyl, methyl, methoxy groups, and an epoxytetradeca[1,11,13]trieno moiety. (12Z,14E,24Z)-5,6,11,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1-oxo-9-propyl-1,2,9,10-tetrahydro-2,8-(epoxytetradeca[1,11,13]trieno)[1]benzofuro[4,5-g]quinazolin-21-yl acetate's extensive structural complexity and the presence of these functional groups suggest potential for bioactivity, which may be harnessed for pharmaceutical applications.
Uses
Used in Pharmaceutical Applications:
(12Z,14E,24Z)-5,6,11,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1-oxo-9-propyl-1,2,9,10-tetrahydro-2,8-(epoxytetradeca[1,11,13]trieno)[1]benzofuro[4,5-g]quinazolin-21-yl acetate may be utilized as a pharmaceutical agent due to its complex molecular structure and the presence of hydroxyl and methoxy groups, which are often associated with bioactivity. The specific applications and therapeutic effects would require further research and testing to determine the compound's safety, efficacy, and mechanism of action.
Check Digit Verification of cas no
The CAS Registry Mumber 62921-37-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,9,2 and 1 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 62921-37:
(7*6)+(6*2)+(5*9)+(4*2)+(3*1)+(2*3)+(1*7)=123
123 % 10 = 3
So 62921-37-3 is a valid CAS Registry Number.
62921-37-3Relevant articles and documents
3-N-substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclization of certain derivatives, and anticellular and antiviral activities of several derivatives
McCarthy,Moore,Wysong,Aldrich
, p. 1272 - 1276 (2007/10/21)
A new synthesis of Mannich bases of rifamycin SV using the Borch procedure with rifaldehyde is described. This new synthesis offers two advantages over the previously published method. It provides a route to monoalkyl-aminomethylrifamycins (1e-h) and to unsubstituted aminomethylrifamycins that were not accessible by the old procedure. The new method also offers a preparative route to Mannich bases 1a and 1b which were needed in multigram quantities for biological testing. In addition, the cyclization of certain of the monoalkylaminomethylrifamycins to the novel N,15 didehydro 15 deoxo 3,15 epi[methano(alkylimino)]rifamycin SV derivatives is described. The anticellular and antiviral effects of representatives of both series of compounds against cultured mouse cells and murine oncornavirus are discussed.